Ingenia Therapeutics Inc

Ingenia Therapeutics Inc. develops biotechnology solutions for blood vessel- related diseases. The company forms research partnerships and transfers technology with pharmaceutical firms, researching antibody-based therapies for ophthalmic, cancer, kidney, and inflammatory diseases. Ingenia Therapeutics serves patients with small vessel diseases in APAC, the US, and Europe.